In case you missed it: April 25 to April 29


A look back at the week's news.

This week's top headlines:

FDA warn public of risks, false results with noninvasive prenatal screening tests

The FDA recently issued a statement warning the public of the risks and potential false results obtained with noninvasive prenatal screening tests, noting that inappropriate usage and interpretation has resulted in improper medical decisions.

Coronavirus Omicron variant, vaccine, and case numbers in the United States: April 28, 2022

Omicron by the numbers.

Women’s health in review: April 2022

A look back at this month’s most popular stories, according to you.

Rotating shift work and onset of menopause

A Canadian study in Menopause suggests shift work may increase women's likelihood to experience delayed onset of menopause.

Prescription spending rose 12% in 2021

A report that tracks the use of medicines in the United States shows that spending on prescriptions rose 12% in 2021 primarily due to COVID-19 vaccines and therapies.

Related Videos
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit:
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit:
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit:
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit:
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit:
raanan meyer, md
Related Content
© 2024 MJH Life Sciences

All rights reserved.